Should patients with prostate cancer and a risk of nodal metastasis >1% undergo standard or limited PLND? Commentary

Nature Clinical Practice Urology

Volumn 5, Issue 1, 2008, Pages 10-11

  Studer, Urs E ^a  

^a PSI   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; CANCER RECURRENCE; CANCER SURVIVAL; DIAGNOSTIC VALUE; GLEASON SCORE; HUMAN; INTERMETHOD COMPARISON; INTERNAL ILIAC ARTERY; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; MORBIDITY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SHORT SURVEY; SURGICAL TECHNIQUE;

EID: 38049128940     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0943     Document Type: Short Survey

References (6)

1. Bader P et al. (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169: 849-854
2. Mattei A et al. (2006) Anatomic localization of prostatic sentinel lymph nodes (SLN) according to fusion imaging of SPECT and CT scans after intraprostatic injection of Technetium-99m-Nanocolloid [abstract 1388]. J Urol 175 (Suppl 4)
3. Schumacher MC et al. (2006) Is pelvic lymph node dissection necessary in patients with a serum PSA<10 ng/ml undergoing radical prostatectomy for prostate cancer? Eur Urol 50: 272-279
4. Daneshmand S et al. (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: Long-term results. J Urol 172: 2252-2255
5. Joslyn SA and Konety BR (2006) Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68: 121-125
6. Di Blasio CJ et al. (2003) Association between number of lymph nodes removed and freedom from disease progression in patients receiving pelvic lymph node dissection during radical prostatectomy for prostate cancer [abstract 1708]. J Urol 169 (Suppl 4)